Drug induced retention of urine
ICD-10 R33.0 is a billable code used to indicate a diagnosis of drug induced retention of urine.
Drug induced retention of urine (R33.0) refers to the inability to void urine due to the effects of certain medications. This condition can arise from various drug classes, including anticholinergics, opioids, and certain antidepressants, which can interfere with the normal function of the bladder and urethra. Symptoms typically include a feeling of fullness in the bladder, discomfort, and an inability to urinate despite the urge. In severe cases, it can lead to urinary retention, which may require catheterization. Clinicians should be aware of the patient's medication history, as well as any recent changes in medication, to identify potential drug-induced causes. Laboratory findings may include elevated post-void residual urine volume, and imaging studies may be necessary to rule out anatomical abnormalities. Proper diagnosis and management are crucial to prevent complications such as urinary tract infections or bladder damage.
Detailed medication history, including dosage and duration of use.
Patients presenting with urinary retention after starting new medications.
Consideration of comorbidities that may exacerbate urinary retention.
Acute assessment of urinary retention, including vital signs and immediate interventions.
Patients with acute urinary retention requiring catheterization.
Rapid identification of drug-induced causes in acute settings.
Used when a patient with drug-induced urinary retention requires catheterization.
Document the reason for catheterization and the patient's medication history.
Emergency medicine may require rapid documentation due to acute presentations.
Common medications include opioids, anticholinergics, certain antidepressants, and antihistamines, which can interfere with bladder function.
